Redeye revises its fair value range after taking a closer look at Q1, an eventful quarter which saw ...
Redeye’s estimates on group level were right on target this time.
Redeye retains its positive view of Binero while making minor forecast adjustments following its Q1’...
Sales +24% y-o-y, +5% vs. ABGSCe We lift ‘22e-‘23e EBIT by 12-13% 13x-12x ’22e-‘23e EV/EBIT, ~25% di...
Sales 2% below and GM of 51% vs ABGSC at 70% Reiterates 2022 outlook with GM of 69-70% Expect small ...
Etteplan reports Q1 results on May 5th. We remain on the cautious side due to the seen increase in s...
Urb-it stärker sin position på befintliga marknader.
Vården har ett stort behov av att på ett säkrare sätt kunna bedöma luftflödet till barnet och vi tro...
Redeye sees a Q1 report with impressive sales growth while margins were somewhat short of our expect...
Atria reported Q1 adjusted EBIT of EUR 2.3m versus Refinitiv consensus at EUR -0.
NoHo Partners will report its Q1 results on 10 May.
We believe Q1 will be negatively affected by Garantia's investment operations, given the current mar...
Q1e EBITDA of SEK 82m 2022 likely another good year for the company Trading at an EV/EBITDA of ~7x f...
Q1 revenues beat cons. by 54%, reaching SEK 78m FY’22 guidance reiterated, despite strong start to t...
Redeye is optimistic about the acquisitions announced today.
Recyctec Holding AB (”Recyctec” eller ”Bolaget”) är verksamma inom återvinning där Bolagets metoder ...
Q1 report exceeding both our and cons. expectations Terra was the shining star with adj.
Atvexa reported a solid Q2, exceeding our expectations despite benefiting from a timing effect.
Redeye ceases its coverage of Nanologica due to the end of the contractual period.
Fortsatt stark organiskt tillväxt... Över lag rapporterade Midway ett mycket imponerande resultat oc...
